0001562180-21-005906.txt : 20210910
0001562180-21-005906.hdr.sgml : 20210910
20210910171631
ACCESSION NUMBER: 0001562180-21-005906
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200427
FILED AS OF DATE: 20210910
DATE AS OF CHANGE: 20210910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linetsky David
CENTRAL INDEX KEY: 0001776729
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38977
FILM NUMBER: 211247824
MAIL ADDRESS:
STREET 1: C/O PHREESIA, INC.
STREET 2: 432 PARK AVENUE S., 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phreesia, Inc.
CENTRAL INDEX KEY: 0001412408
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 434 FAYETTEVILLE ST.
STREET 2: SUITE 1400
CITY: RALEIGH
STATE: NC
ZIP: 27601
BUSINESS PHONE: 646-747-9959
MAIL ADDRESS:
STREET 1: 434 FAYETTEVILLE ST.
STREET 2: SUITE 1400
CITY: RALEIGH
STATE: NC
ZIP: 27601
FORMER COMPANY:
FORMER CONFORMED NAME: Phreesia Inc
DATE OF NAME CHANGE: 20070914
4/A
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4/A
2020-04-27
2020-04-29
false
0001412408
Phreesia, Inc.
PHR
0001776729
Linetsky David
C/O PHREESIA, INC.
434 FAYETTEVILLE ST., SUITE 1400
RALEIGH
NC
27601
false
true
false
false
SVP, Life Sciences
Stock Options (Right to buy)
4.71
2020-04-27
4
M
false
1376.00
0.00
D
2028-08-06
Common Stock
1376.00
32756.00
D
25% of this option vested and became exercisable on August 7, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
The original Form 4, filed on April 29, 2020, is being amended by this Form 4 amendment to correct the number of derivative securities beneficially owned by the Reporting Person after the reported transaction.
/s/ Allison Hoffman by Power of Attorney for David Linetsky
2021-09-10